Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dieda Wanying is a Traditional Chinese Medicine (TCM) formulation developed as an in-hospital preparation by the Huguo Temple Hospital of Traditional Chinese Medicine, which is affiliated with the Beijing University of Chinese Medicine. It is primarily indicated for the treatment of acute soft tissue injuries, specifically acute ankle contusions and sprains. The medication is formulated based on TCM principles to promote blood circulation, resolve blood stasis (Huoxue Huayu), reduce localized swelling, and provide analgesic relief. It is typically administered topically to the site of injury, often in the form of a tincture (Ding) or a plaster (Gao), to facilitate rapid recovery and improve joint mobility following trauma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dieda Wanying.